1. Home
  2. ELDN vs PCYO Comparison

ELDN vs PCYO Comparison

Compare ELDN & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.98

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

HOLD

Current Price

$10.64

Market Cap

249.5M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELDN
PCYO
Founded
2004
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Water Supply
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
291.8M
249.5M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
ELDN
PCYO
Price
$3.98
$10.64
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.9M
60.7K
Earning Date
05-12-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
30.67
12.50
EPS
N/A
0.36
Revenue
N/A
$1,227,787.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$29.21
Revenue Growth
N/A
171.54
52 Week Low
$1.35
$9.65
52 Week High
$4.60
$12.44

Technical Indicators

Market Signals
Indicator
ELDN
PCYO
Relative Strength Index (RSI) 55.11 46.50
Support Level $3.44 $9.77
Resistance Level $4.09 $11.05
Average True Range (ATR) 0.28 0.37
MACD 0.00 -0.03
Stochastic Oscillator 53.68 47.13

Price Performance

Historical Comparison
ELDN
PCYO

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: